SMT201700003B - Didropiridoni come inibitori del fattore xia - Google Patents
Didropiridoni come inibitori del fattore xiaInfo
- Publication number
- SMT201700003B SMT201700003B SM201700003T SM201700003T SMT201700003B SM T201700003 B SMT201700003 B SM T201700003B SM 201700003 T SM201700003 T SM 201700003T SM 201700003 T SM201700003 T SM 201700003T SM T201700003 B SMT201700003 B SM T201700003B
- Authority
- SM
- San Marino
- Prior art keywords
- didropyridons
- inhibitors
- xia factor
- xia
- factor
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261679197P | 2012-08-03 | 2012-08-03 | |
| US201361786992P | 2013-03-15 | 2013-03-15 | |
| PCT/US2013/053414 WO2014022766A1 (en) | 2012-08-03 | 2013-08-02 | Dihydropyridone p1 as factor xia inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201700003B true SMT201700003B (it) | 2017-03-08 |
Family
ID=48949289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201700003T SMT201700003B (it) | 2012-08-03 | 2017-01-04 | Didropiridoni come inibitori del fattore xia |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US9376444B2 (it) |
| EP (1) | EP2882734B1 (it) |
| JP (1) | JP6082462B2 (it) |
| KR (1) | KR20150038369A (it) |
| AR (1) | AR093759A1 (it) |
| AU (1) | AU2013296258A1 (it) |
| BR (1) | BR112015002293A2 (it) |
| CA (1) | CA2880898A1 (it) |
| CY (1) | CY1118450T1 (it) |
| DK (1) | DK2882734T3 (it) |
| EA (1) | EA025392B1 (it) |
| ES (1) | ES2605824T3 (it) |
| HR (1) | HRP20161378T1 (it) |
| HU (1) | HUE031582T2 (it) |
| IL (1) | IL237012A0 (it) |
| LT (1) | LT2882734T (it) |
| MX (1) | MX361370B (it) |
| PL (1) | PL2882734T3 (it) |
| PT (1) | PT2882734T (it) |
| RS (1) | RS55581B1 (it) |
| SG (1) | SG11201500270RA (it) |
| SI (1) | SI2882734T1 (it) |
| SM (1) | SMT201700003B (it) |
| TW (1) | TW201410666A (it) |
| UY (1) | UY34959A (it) |
| WO (1) | WO2014022766A1 (it) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201319068A (zh) | 2011-08-05 | 2013-05-16 | 必治妥美雅史谷比公司 | 作為ｘｉａ因子抑制劑之環狀ｐ１接合劑 |
| TW201311689A (zh) | 2011-08-05 | 2013-03-16 | 必治妥美雅史谷比公司 | 作為因子ｘｉａ抑制劑之新穎巨環化合物 |
| US9108951B2 (en) | 2011-10-14 | 2015-08-18 | Bristol-Myers Squibb Company | Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitors |
| IN2014CN02805A (it) | 2011-10-14 | 2015-07-03 | Bristol Myers Squibb Co | |
| ES2625256T3 (es) | 2011-10-14 | 2017-07-19 | Bristol-Myers Squibb Company | Compuestos de tetrahidroisoquinolina sustituidos como inhibidores del factor XIA |
| KR102143257B1 (ko) | 2012-10-12 | 2020-08-10 | 브리스톨-마이어스 스큅 컴퍼니 | 인자 XIa 억제제의 결정질 형태 |
| US9315519B2 (en) | 2012-10-12 | 2016-04-19 | Bristol-Myers Squibb Company | Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitors |
| US9403774B2 (en) | 2012-10-12 | 2016-08-02 | Bristol-Myers Squibb Company | Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| ES2712699T3 (es) | 2013-03-25 | 2019-05-14 | Bristol Myers Squibb Co | Tetrahidroisoquinolinas que contienen azoles sustituidos como inhibidores del factor XIa |
| TWI633089B (zh) * | 2013-03-28 | 2018-08-21 | 拜耳製藥股份有限公司 | 經取代的酮基吡啶衍生物 |
| NO2760821T3 (it) * | 2014-01-31 | 2018-03-10 | ||
| TWI688564B (zh) * | 2014-01-31 | 2020-03-21 | 美商必治妥美雅史谷比公司 | 作為凝血因子ｘｉａ抑制劑之具有雜環p2'基團之巨環化合物 |
| US9663527B2 (en) | 2014-02-11 | 2017-05-30 | Merck Sharp & Dohme Corp. | Factor XIa inhibitors |
| EP3104703B1 (en) * | 2014-02-11 | 2020-11-18 | Merck Sharp & Dohme Corp. | Factor xia inhibitors |
| CN107074821B (zh) | 2014-09-04 | 2020-05-22 | 百时美施贵宝公司 | 为fxia抑制剂的二酰胺大环化合物 |
| NO2721243T3 (it) | 2014-10-01 | 2018-10-20 | ||
| US9453018B2 (en) | 2014-10-01 | 2016-09-27 | Bristol-Myers Squibb Company | Pyrimidinones as factor XIa inhibitors |
| WO2016205482A1 (en) | 2015-06-19 | 2016-12-22 | Bristol-Myers Squibb Company | Diamide macrocycles as factor xia inhibitors |
| CN107849026B (zh) | 2015-07-29 | 2021-01-01 | 百时美施贵宝公司 | 携带烷基或环烷基p2′部分的因子xia大环抑制剂 |
| EP3328852B1 (en) | 2015-07-29 | 2021-04-28 | Bristol-Myers Squibb Company | Factor xia macrocyclic inhibitors bearing a non-aromatic p2' group |
| WO2017074833A1 (en) | 2015-10-29 | 2017-05-04 | Merck Sharp & Dohme Corp. | Macrocyclic spirocarbamate derivatives as factor xia inhibitors, pharmaceutically acceptable compositions and their use |
| CN108430471B (zh) * | 2015-10-29 | 2021-07-09 | 默沙东公司 | 因子XIa抑制剂 |
| WO2017151746A1 (en) * | 2016-03-02 | 2017-09-08 | Bristol-Myers Squibb Company | Diamide macrocycles having factor xia inhibiting activity |
| WO2018039094A1 (en) | 2016-08-22 | 2018-03-01 | Merck Sharp & Dohme Corp. | Pyridine-1-oxide derivatives and their use as factor xia inhibitors |
| WO2020211781A1 (zh) | 2019-04-16 | 2020-10-22 | 南京明德新药研发有限公司 | 作为XIa因子抑制剂的大环衍生物 |
| CN114008047B (zh) * | 2019-07-23 | 2023-03-21 | 南京明德新药研发有限公司 | 作为XIa因子抑制剂的大环衍生物 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3065190D1 (en) | 1979-11-05 | 1983-11-10 | Beecham Group Plc | Enzyme derivatives, and their preparation |
| PE121699A1 (es) | 1997-02-18 | 1999-12-08 | Boehringer Ingelheim Pharma | Heterociclos biciclicos disustituidos como inhibidores de la trombina |
| ZA985247B (en) | 1997-06-19 | 1999-12-17 | Du Pont Merck Pharma | Guanidine mimics as factor Xa inhibitors. |
| WO2000076970A2 (en) | 1999-06-14 | 2000-12-21 | Eli Lilly And Company | Serine protease inhibitors |
| DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| AR035216A1 (es) | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
| BRPI0212726B8 (pt) | 2001-09-21 | 2021-05-25 | Bristol Myers Squibb Co | compostos contendo lactamas, e derivados dos mesmos, composição farmacêutica que os compreende e seus usos |
| US20040180855A1 (en) | 2003-02-19 | 2004-09-16 | Schumacher William A. | Methods of treating thrombosis with reduced risk of increased bleeding times |
| US7138412B2 (en) | 2003-03-11 | 2006-11-21 | Bristol-Myers Squibb Company | Tetrahydroquinoline derivatives useful as serine protease inhibitors |
| US7129264B2 (en) | 2003-04-16 | 2006-10-31 | Bristol-Myers Squibb Company | Biarylmethyl indolines and indoles as antithromboembolic agents |
| US7417063B2 (en) | 2004-04-13 | 2008-08-26 | Bristol-Myers Squibb Company | Bicyclic heterocycles useful as serine protease inhibitors |
| US7453002B2 (en) | 2004-06-15 | 2008-11-18 | Bristol-Myers Squibb Company | Five-membered heterocycles useful as serine protease inhibitors |
| US7429604B2 (en) | 2004-06-15 | 2008-09-30 | Bristol Myers Squibb Company | Six-membered heterocycles useful as serine protease inhibitors |
| WO2006076575A2 (en) | 2005-01-13 | 2006-07-20 | Bristol-Myers Squibb Company | Substituted biaryl compounds as factor xia inhibitors |
| WO2006089005A2 (en) | 2005-02-17 | 2006-08-24 | Bristol-Myers Squibb Company | Combination of selective factor viia and/or xia and plasma kallikrein inhibitors |
| ATE511502T1 (de) | 2005-12-14 | 2011-06-15 | Bristol Myers Squibb Co | Arylpropionamid-, arylacrylamid-, arylpropinamid- oder arylmethylharnstoffanaloge als faktor-xia- inhibitoren |
| KR20080080173A (ko) | 2005-12-14 | 2008-09-02 | 브리스톨-마이어스 스큅 컴퍼니 | 세린 프로테아제 억제제로서 유용한 6-원 헤테로사이클 |
| US8466295B2 (en) | 2005-12-14 | 2013-06-18 | Bristol-Myers Squibb Company | Thiophene derivatives as factor XIa inhibitors |
| JP5342450B2 (ja) | 2006-12-15 | 2013-11-13 | ブリストル−マイヤーズ スクイブ カンパニー | 第ＸＩａ因子インヒビターとしてのアリールプロピオンアミド、アリールアクリルアミド、アリールプロピンアミド、またはアリールメチルウレアアナログ |
| PE20081775A1 (es) * | 2006-12-20 | 2008-12-18 | Bristol Myers Squibb Co | Compuestos macrociclicos como inhibidores del factor viia |
| CN101784516B (zh) | 2007-06-13 | 2014-07-02 | 百时美施贵宝公司 | 作为凝血因子抑制剂的二肽类似物 |
| ES2380648T3 (es) | 2008-03-13 | 2012-05-17 | Bristol-Myers Squibb Company | Derivados de piridazina como inhibidores del factor XIA |
| SG183153A1 (en) | 2010-02-11 | 2012-09-27 | Bristol Myers Squibb Co | Macrocycles as factor xia inhibitors |
| TW201319068A (zh) | 2011-08-05 | 2013-05-16 | 必治妥美雅史谷比公司 | 作為ｘｉａ因子抑制劑之環狀ｐ１接合劑 |
| TW201311689A (zh) * | 2011-08-05 | 2013-03-16 | 必治妥美雅史谷比公司 | 作為因子ｘｉａ抑制劑之新穎巨環化合物 |
| IN2014CN02805A (it) | 2011-10-14 | 2015-07-03 | Bristol Myers Squibb Co | |
| US9108951B2 (en) | 2011-10-14 | 2015-08-18 | Bristol-Myers Squibb Company | Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitors |
| ES2625256T3 (es) | 2011-10-14 | 2017-07-19 | Bristol-Myers Squibb Company | Compuestos de tetrahidroisoquinolina sustituidos como inhibidores del factor XIA |
| KR102011534B1 (ko) | 2011-12-21 | 2019-08-16 | 오노 야꾸힝 고교 가부시키가이샤 | 인자 ＸＩａ 억제제로서 피리디논 및 피리미디논 유도체 |
| JP2015083542A (ja) | 2012-02-08 | 2015-04-30 | 大日本住友製薬株式会社 | ３位置換プロリン誘導体 |
| GB201209138D0 (en) | 2012-05-24 | 2012-07-04 | Ono Pharmaceutical Co | Compounds |
-
2013
- 2013-08-02 TW TW102127904A patent/TW201410666A/zh unknown
- 2013-08-02 UY UY0001034959A patent/UY34959A/es unknown
- 2013-08-02 PT PT137476248T patent/PT2882734T/pt unknown
- 2013-08-02 SI SI201330344A patent/SI2882734T1/sl unknown
- 2013-08-02 US US14/419,014 patent/US9376444B2/en active Active
- 2013-08-02 PL PL13747624T patent/PL2882734T3/pl unknown
- 2013-08-02 CA CA2880898A patent/CA2880898A1/en not_active Abandoned
- 2013-08-02 JP JP2015525621A patent/JP6082462B2/ja active Active
- 2013-08-02 DK DK13747624.8T patent/DK2882734T3/en active
- 2013-08-02 HU HUE13747624A patent/HUE031582T2/en unknown
- 2013-08-02 KR KR20157004959A patent/KR20150038369A/ko not_active Application Discontinuation
- 2013-08-02 EA EA201590284A patent/EA025392B1/ru not_active IP Right Cessation
- 2013-08-02 US US13/957,609 patent/US20140038969A1/en not_active Abandoned
- 2013-08-02 MX MX2015000919A patent/MX361370B/es active IP Right Grant
- 2013-08-02 RS RS20170019A patent/RS55581B1/sr unknown
- 2013-08-02 ES ES13747624.8T patent/ES2605824T3/es active Active
- 2013-08-02 EP EP13747624.8A patent/EP2882734B1/en active Active
- 2013-08-02 WO PCT/US2013/053414 patent/WO2014022766A1/en active Application Filing
- 2013-08-02 SG SG11201500270RA patent/SG11201500270RA/en unknown
- 2013-08-02 BR BR112015002293A patent/BR112015002293A2/pt not_active Application Discontinuation
- 2013-08-02 LT LTEP13747624.8T patent/LT2882734T/lt unknown
- 2013-08-02 AR ARP130102762A patent/AR093759A1/es unknown
- 2013-08-02 AU AU2013296258A patent/AU2013296258A1/en not_active Abandoned
-
2015
- 2015-01-29 IL IL237012A patent/IL237012A0/en unknown
-
2016
- 2016-10-24 HR HRP20161378TT patent/HRP20161378T1/hr unknown
-
2017
- 2017-01-04 SM SM201700003T patent/SMT201700003B/it unknown
- 2017-01-10 CY CY20171100026T patent/CY1118450T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20150166550A1 (en) | 2015-06-18 |
| WO2014022766A1 (en) | 2014-02-06 |
| HRP20161378T1 (hr) | 2016-12-02 |
| EA025392B1 (ru) | 2016-12-30 |
| HUE031582T2 (en) | 2017-07-28 |
| RS55581B1 (sr) | 2017-06-30 |
| IL237012A0 (en) | 2015-03-31 |
| PT2882734T (pt) | 2016-12-09 |
| MX2015000919A (es) | 2015-09-21 |
| BR112015002293A2 (pt) | 2017-07-04 |
| ES2605824T3 (es) | 2017-03-16 |
| EP2882734A1 (en) | 2015-06-17 |
| SI2882734T1 (sl) | 2017-01-31 |
| TW201410666A (zh) | 2014-03-16 |
| EP2882734B1 (en) | 2016-10-12 |
| AR093759A1 (es) | 2015-06-24 |
| MX361370B (es) | 2018-12-05 |
| US20140038969A1 (en) | 2014-02-06 |
| SG11201500270RA (en) | 2015-03-30 |
| CN104520289A (zh) | 2015-04-15 |
| UY34959A (es) | 2014-01-31 |
| PL2882734T3 (pl) | 2017-05-31 |
| CA2880898A1 (en) | 2014-02-06 |
| US9376444B2 (en) | 2016-06-28 |
| KR20150038369A (ko) | 2015-04-08 |
| JP2015524443A (ja) | 2015-08-24 |
| EA201590284A1 (ru) | 2015-05-29 |
| CY1118450T1 (el) | 2017-06-28 |
| LT2882734T (lt) | 2016-12-12 |
| AU2013296258A1 (en) | 2015-03-19 |
| JP6082462B2 (ja) | 2017-02-15 |
| DK2882734T3 (en) | 2017-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201700003B (it) | Didropiridoni come inibitori del fattore xia | |
| SMT201700053B (it) | Derivato del cicloalcano | |
| DK2859055T3 (da) | Polymercoatings | |
| DK2825087T3 (da) | Otoscanner | |
| DK2839013T3 (da) | Ikke-disruptiv-gen-targetering | |
| DK3293183T3 (da) | Hæmmerforbindelser | |
| CO6990736A2 (es) | Pirrolidina-2-carboxamidas sustituídas | |
| DK2873977T3 (da) | Dobbeltdækker-rørdispenser | |
| DE112012006109A5 (de) | Okklusionsschienenanordnung | |
| DK2854722T3 (da) | Stomipose | |
| DK2825157T3 (da) | Aminosyrelipider | |
| DK2831122T3 (da) | Anthocyanidin-kompleks | |
| DE112012006214T8 (de) | Wulstringwickler | |
| DE112012005566T8 (de) | Seltenerdnanoverbundmagnet | |
| FI20126082A (fi) | Kaasunvaihtoventtiilijärjestely | |
| DK2885638T3 (da) | Molekylenet | |
| DK2858657T3 (da) | Feijoafrugtekstrakt | |
| FI20125844A (fi) | Talotekniikkamoduuli | |
| ES1077590Y (es) | Columbario | |
| DE102013212400A8 (de) | Abdeckplattenstützbaugruppe | |
| DK2897570T3 (da) | Spin-elueringsrør | |
| FI20126064A (fi) | Leijupetilämmönvaihdin | |
| ES1077210Y (es) | Columbario cinerario | |
| DE202012013401U8 (de) | Bioextruder | |
| FI20125436A (fi) | Pienvenetelakka |